Pregnancy - Articles - Page 3 | CARLAT PUBLISHING

Lithium Exposure In Utero—How Bad Is It Really?

July 1, 2022

Victoria Hendrick, MD. and Lara Tang, MD

Lara Tang, MD, and Victoria Hendrick, MD. Dr. Tang and Dr. Hendrick have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We know prenatal lithium exposure increases the risk of heart defects in newborns. By keeping lithium doses and blood levels under certain cut-off points, we can reduce this risk, according to this large meta-analysis.

Unintended Pregnancies in Opioid Use Disorder

March 1, 2022

Peter J. Farago, MD.

Peter J. Farago, MD. Dr. Farago has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Rates of unintended pregnancies are high among patients with opioid use disorder (OUD). In this study, researchers tested the efficacy of co-locating contraceptive services with treatment for OUD as well as the efficacy of providing financial incentives.

The Pregnant Patient With Substance Use Disorder

July 3, 2021

Ariadna Forray, MD

Ariadna Forray, MD
Associate Professor of Psychiatry, Yale School of Medicine, New Haven, CT. Interim Chief, Section of Psychological Medicine. Director, Center for Wellbeing of Women and Mothers, Yale New Haven Hospital. Dr. Forray has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Forray gives readers a comprehensive refresher on fetal effects of alcohol, tobacco, opioid, cannabis, and stimulant use during pregnancy. She then lays out the current evidence for various treatments and provides recommendations for how to treat pregnant patients with addiction.

Capacity Assessment in Pregnant Patients

May 21, 2021

Saba Syed, MD

Saba Syed, MD Director of Consultation and Liaison Psychiatry, Olive View-UCLA Medical Center. Clinical Professor, UCLA. Bioethics Committee Chair, Olive View-UCLA Medical Center. Consultation-Liaison, Olive View Medical Center, Los Angeles, CA. Dr. Syed has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Imagine working with a pregnant, mentally ill woman who refuses critical obstetric interventions. Dr. Syed walks us through the steps to determine if these patients lack decisional capacity and explains how we can arrange for surrogate decision-makers.

Buspirone: Still Effective After All These Years?

February 3, 2021

Eugene Rubin, MD.

Eugene Rubin, MD. Psychiatrist in private practice, Bingham Farms, MI. Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Buspirone (Buspar) is approved for generalized anxiety disorder, but its efficacy there is often questioned. Here we find out how it stacks up against the benzos and SSRIs, and explore its off-label potential in depression, sexual dysfunction, alcoholism, traumatic brain injury, and premenstrual dysphoric disorder.

Brexanolone (Zulresso) for Postpartum Depression

July 3, 2019

Talia Puzantian, Chris Aiken, MD, and Chris Aiken

Talia Puzantian, PharmD, BCPP Chris Aiken, MD Drs. Puzantian and Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Every week of depression takes a toll on infant development, so this rapid-acting treatment fills a unique need. Here we review the clinical data and the pragmatics of getting patients connected with the therapy.

What Can Our Pregnant Patients Do to Prevent Mental Illness in Their Children?

March 29, 2019

Robert Freedman, MD

Robert Freedman, MD

Professor and Former Chairman, Department of Psychiatry, University of Colorado-Denver. Editor Emeritus, American Journal of Psychiatry.

Dr. Freedman has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

During pregnancy, untreated depression significantly increases the risk that the infant will fail to develop adequate levels of cerebral inhibition. That’s a measure of the infant’s ability to filter out irrelevant stimuli, and it’s the first sign that development is not on an optimal track.

Breast-feeding and Antidepressants: An Update

May 1, 2003

Daniel Carlat, MD

Daniel Carlat, MD Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.

There’s nothing like a close friend suffering psychiatric difficulties to motivate a psychiatrist to do some serious reading. Recently, your humble editor encountered this situation.

SSRIs in Pregnancy: Third Trimester Concerns

May 1, 2003

Daniel Carlat, MD

Daniel Carlat, MD Dr. Carlat has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.

You may not know it, but this year marks a milestone in the world of SSRI teratology research. Ten years ago, JAMA published the first controlled study of Prozac exposure in pregnancy (1). The results? Neither Prozac nor tricyclics caused more birth defects than controls, but both antidepressants caused more neonatal complications.

Dr. Victoria Hendrick on Using Meds in Pregnancy

May 1, 2003

Victoria Hendrick, MD.

Victoria Hendrick, M.D. Director of Pregnancy and Postpartum Mood Disorders Program Assistant Professor of Psychiatry and Biobehavioral Sciences University of California, Los Angeles

Dr. Hendrick, there has been a lot of confusing and seemingly contradictory data about the safety of SSRIs during pregnancy. What’s your take?